NCT03901404

Brief Summary

Myomectomy operation due to myoma uteri is an operation that can cause serious blood loss. For some anatomical reasons, fundal myomas were removed, while a group of investigators recommended the initiation of a longitudinal incision and some surgeons preferred a transverse incision. the authors aim to show some surgical differences, intraoperative blood loss, and difficulties and ease of removal of myoma in patients with these approaches without consensus. It is also noted that the incision made with the same energy modality is recorded; The effect of energy modality on blood loss and surgical comfort will be examined. Different approaches are used for laparoscopic surgical operations in order to remove myoma from the abdomen. It can be removed from the vagina by colpotomy and can also be minimized in the abdomen by a morselator. In particular, patients with vaginal myoma removed, such as complaints of postoperative dyspareunia will be followed. In this way, the investigators aim to evaluate the methods which have not yet gained clarity in the literature or have not proven superiority to each other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

June 23, 2022

Status Verified

June 1, 2022

Enrollment Period

3 years

First QC Date

April 1, 2019

Last Update Submit

June 22, 2022

Conditions

Keywords

MyomectomyFundus IncisionEnergy ModalitiesMethods of Extraction

Outcome Measures

Primary Outcomes (3)

  • Fundus Incision

    In patients undergoing myomectomy, the incision used by the surgeon will be recorded to remove myoma. to be recorded as transverse or vertical.

    3 months

  • Energy Modalities

    In patients undergoing myomectomy, the energy modality used by the surgeon will be recorded to remove the myoma. bipolari, monopolar or ultrasonic

    3 months

  • Methods of Extraction

    In patients undergoing myomectomy operation, the method used by the surgeon to remove myoma from the abdomen will be recorded. morselator, vaginally with colpotomi

    3 months

Interventions

Patients undergoing myomectomy for myoma uteri

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients operated with the diagnosis of myoma uteri

You may qualify if:

  • \- Patients operated with the diagnosis of myoma uteri

You may not qualify if:

  • Cardiopulmonary diseases such as cardiac insufficiency, myocardial infarction, unstable angina, acute or new vascular thrombosis, asthma or pulmonary obstructive disease;
  • Patients with long-term Trendelenburg contraindications;
  • Previous pelvic or abdominal radiation therapy; or those with inadequate bone marrow, kidney and hepatic function;
  • Gynecological malignancies.
  • Those who received preoperative medication due to myoma uteri

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Süleyman Training and Research Hospital

Istanbul, 33404, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Myofibroma

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator, M.D, Department of Obstetrics and GynecologyR

Study Record Dates

First Submitted

April 1, 2019

First Posted

April 3, 2019

Study Start

April 1, 2019

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

June 23, 2022

Record last verified: 2022-06

Locations